MgO or SrSO 4 particulates were introduced into Bi-2212/Ag tapes during the fabrication process with the intention of producing flux pinning centres. It was found that (i) MgO or SrSO 4 normal particles added to Bi-2212 superconductor do not react chemically with or corrupt the Bi-2212 phase, but MgO may alter the phase evolution during the partial melting and the solidification of Bi-2212 and reduce the second-phase inclusions, (ii) MgO addition may enhance the flux pinning potential in a certain region of temperature and magnetic field (the contributions of MgO addition to the flux pinning potential are still not clear) and (iii) SrSO 4 addition appears to have no effect on the properties of finished samples.
With the aid of transmission electron microscopy, the phenomenon of additional superstructure along [Formula: see text] direction was observed for a sample of Bi 1.7 Pb 0.3Sr2 Ca 1.8 Ba 0.2 Cu 3 O y, and two kinds of modulation mode along b axis was found to coexist in this sample. The images of SEM showed that the addition of Ba ions improved the property of two-dimensional growth. The results of XRD indicated that the substitution of Ba 2+ for Ca 2+ increased the volume fraction of the high-Tc phase (Tc>100 K). From the initial part of dc magnetization curve, it is estimated that about 36 percent of the sample volume is in the 110 K superconducting phase at 77 K. Its frozen magnetic flux density is about 8.6 G, which is 5–6 G higher than that of general Pb-doped sample, and its zero-resistance temperature can reach as high as 111 K. These changes of physical properties may be related to the adjustment of the microstructure.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.